Counterion and Salt Form

A peptide carrying ionisable side chains is almost never isolated neutral; it emerges from purification as a salt, with counterions balancing each charged group. A sequence with several basic residues associates with several equivalents of an acid anion, so the counterion, with residual water and inorganic salt, occupies part of the mass of any weighed powder. Net peptide content states how much of that mass is peptide, and it is a separate measurement from chromatographic purity.

Counterion identity is set by the final purification step. Reversed-phase HPLC is conventionally run with trifluoroacetic acid as an ion-pairing agent, so research-grade material typically arrives as the TFA salt, where in a strongly basic peptide the counterion can account for a substantial fraction of total mass. Approved parenteral products generally avoid it, with leuprolide, octreotide and glatiramer supplied as acetate salts; conversion requires a deliberate, documented ion-exchange step.

The consequence is that milligrams of powder and milligrams of peptide are different quantities, and the gap can reach tens of percent. That affects anything computed from a weight, including molar concentrations in an assay and cost comparisons between products whose salt forms differ. Trifluoroacetate also has biological activity of its own, altering cell behaviour in culture at concentrations reachable from an incompletely exchanged preparation.

The specific misreading is treating a stated milligram figure as peptide mass. A vial labelled with a nominal quantity of an acetate salt contains less peptide than the same nominal quantity of free base, and a certificate reporting purity by chromatographic area while omitting net peptide content, water and counterion content has quantified the wrong thing. Chromatographic purity describes the peptide fraction, not how large that fraction is.